Benjamin M. Kuter

MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas

Naema Nayyar, Michael White, Corey M. Gill et al. · Blood Advances · 2019 · 127 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases

Franziska M. Ippen, Julia Grosch, Megha Subramanian et al. · Neuro-Oncology · 2019 · 99 citations · Full text

Medicine, Oncology, Pharmacology +17

The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in <i>PIK3CA</i> -Mutant Breast Cancer Brain Metastases

Franziska M. Ippen, Christopher Alvarez‐Breckenridge, Benjamin M. Kuter et al. · Clinical Cancer Research · 2019 · 87 citations · Full text

Medicine, Oncology, Pharmacology +17

DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome

Tareq A. Juratli, Devin McCabe, Naema Nayyar et al. · Acta Neuropathologica · 2018 · 83 citations

Life Sciences, Genetics, Neuroscience +7

Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid

Michael White, Robert H. Klein, Brian Shaw et al. · JAMA Network Open · 2021 · 82 citations · Full text

Medicine, Oncology, Pathology +17